pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 29·1 min read
save

26 states file lawsuit to halt federal Medicaid work-requirement rule

Jun 29, 2026·read at STAT ↗RegulatoryNegative

Five New England states joined 21 others in a lawsuit filed Monday to stop a federal rule that would add work requirements to Medicaid. The states argue the new guidelines create an unfair bureaucratic maze for people who are entitled to coverage.

The rule, released this month, would require most Medicaid recipients ages 19 to 64 to prove they work, attend school or volunteer for at least 80 hours each month.

State officials say the requirement could cause hundreds of thousands of residents, including many in Massachusetts, to lose their health insurance and they are racing to meet a Jan 1 deadline for implementation.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: 26 states sue to block Medicaid work requirements”

read at STAT ↗
406 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLY
drugs
Obesity
topics
GLP-1 receptorHematologyObesity

related stories

  • 6d agoLilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist MounjaroBioSpace
  • Aug 21Novo Nordisk starts trialing lower maintenance doses of oral WegovyBioSpace
  • Aug 19Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, moreBioSpace
  • Aug 19Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?BioSpace
  • Aug 5Lilly climbs, Novo falls as obesity drug battle intensifiesBioPharma Dive